Technology

VivoSense, which develops wearable biometric sensors to collect and organize data from patients for clinical drug trials, raises a $25M Series A (Keerthi Vedantam/dot.LA)

[ad_1]

Keerthi Vedantam / dot.LA:

VivoSense, which develops wearable biometric sensors to collect and organize data from patients for clinical drug trials, raises a $25M Series A  —  As the CEO of Sarepta Therapeutics from 2011 to 2015, Chris Garabedian led a biotech firm striving to find cures for rare diseases.



[ad_2]

Share this news on your Fb,Twitter and Whatsapp

File source

Times News Network:Latest News Headlines
Times News Network||Health||New York||USA News||Technology||World News

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close